retatrutide mechanism triple agonist glp-1 gip glucagon ly3437943 A review of an investigational drug retatrutide, a novel agent for the treatment of obesity | European Journal of Clinical Pharmacology Retatrutide vs Tirzepatide: Triple vs

The impact once-weekly semaglutide 2.4 mg will have on clinical practice: a focus on the STEP trials

Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1

Severe abdominal pain Abdominal distension

Patients should be aware that severe or persistent abdominal pain may be a sign of pancreatitis or a gallbladder complication, consistent with the GLP-1 receptor agonist class, and warrants urgent medical assessment

Tissue-specific expression of unique mRNAs that encode proglucagon-derived peptides or exendin 4 in the lizard

however, it is important to note that glucagon receptor activation also stimulates hepatic glucose production, and the net metabolic effect of this component in humans is still being characterised